What is Syntr Health Technologies?
Syntr Health Technologies, Inc., established in 2018 and headquartered in Irvine, California, is a medical technology company focused on revolutionizing adipose tissue processing at the point of care. Founded by three engineers, the company emerged following a successful NIH Phase I SBIR grant. Syntr Health Technologies aims to become the market leader in automated adipose tissue processing, with the goal of reducing patient recovery times and enhancing quality of life. Its strategic location within University Lab Partners, a prominent wet lab incubator, facilitates its research and development efforts.
How much funding has Syntr Health Technologies raised?
Syntr Health Technologies has raised a total of $2.2M across 1 funding round:
Angel/Seed
$2.2M
Angel/Seed (2021): $2.2M, investors not publicly disclosed
What's next for Syntr Health Technologies?
The recent major strategic investment signifies a pivotal moment for Syntr Health Technologies, likely enabling the company to scale its operations, advance its product development, and expand its market reach. This enterprise-level backing suggests confidence from investors in Syntr's technology and its potential to disrupt the medical device sector, particularly in procedures involving adipose tissue. The company is poised for significant growth and market penetration as it moves towards commercialization.
See full Syntr Health Technologies company page
